Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
-0.04 (-2.26%)
At close: Aug 19, 2025, 1:39 PM
Gain Therapeutics Revenue
Gain Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Gain Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
23
Market Cap
62.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 55.18K | -60.62% |
| Dec 31, 2022 | 140.11K | -15.08% |
| Dec 31, 2021 | 164.99K | +471.29% |
| Dec 31, 2020 | 28.88K | -30.07% |
| Dec 31, 2019 | 41.3K | +100.40% |
| Dec 31, 2018 | 20.61K | n/a |